Insider filing · TVTX
Timothy Coughlin
Director
profile →
Travere Therapeutics, Inc.
TVTX · Healthcare · 74 filings in 24 months
ticker →
Timothy Coughlin sold $501K of Travere Therapeutics (TVTX)
Executed Jun 12, disclosed Jun 16, 4 days later.
Value, as filed
$501K
10,000 sh × $50.07
Executed
Jun 12
the trade date, as filed
Disclosed
Jun 16
4 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
TCTimothy Coughlin (Director) filed 3 Form 4 reports in the trailing twelve months (0 purchases, 3 sales), most often in Travere Therapeutics, Inc. (TVTX). The largest single filing was $631K of TVTX (18,000 sh × $35.03, as filed), executed Oct 31 2025.
The name
TVTXHealthcare · Travere Therapeutics, Inc., a biopharmaceutical company, identifies, develops, and delivers therapies to people living with rare kidney and…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→Other filings by Timothy Coughlin in TVTX
TVTXSALE
Travere Therapeutics, Inc.
$141K3,250 sh × $43.49
Exec May 15
Filed May 19 · 5:30 PM ET TVTXSALE Travere Therapeutics, Inc. $631K
18,000 sh × $35.03
Exec Oct 31 2025
Filed Nov 4 2025 · 5:30 PM ET